93 7455
Pill imprint 93 7455 has been identified as Glipizide and metformin 2.5 mg / 250 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy.
Glipizide/metformin 2.5 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Glipizide and metformin Images
- Imprint:
-
93
7455 - Strength:
- 2.5 mg / 250 mg
- Color:
- Pink
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone
corn starch
magnesium silicate
titanium dioxide
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7455
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00555-0625 | Barr Laboratories Inc |
| 00591-3971 | Watson Pharmaceuticals, Inc. |
Note: Inactive ingredients may vary.
Advertisement
More Glipizide and Metformin resources
- Glipizide/Metformin (Wolters Kluwer)
- glipizide and metformin (Cerner Multum)
- glipizide and metformin (Micromedex) - Includes Dosage Information
- Glipizide and Metformin (FDA)
- Glipizide/Metformin Hydrochloride (Wolters Kluwer)
Search Again
